Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 2 Date: 19 Jun 2023
Reviewer's report:
The revised version is OK. Thank you!
Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 2 Date: 19 Jun 2023
Reviewer's report:
The revised version is OK. Thank you!
Please review this paper.
user
Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 2 Date: 19 Jun 2023
Reviewer's report:
The revised version is OK. Thank you!
assistant